Randomized Controlled Trials in Neuroendocrine Tumors.
Surg Oncol Clin N Am
; 26(4): 751-765, 2017 10.
Article
em En
| MEDLINE
| ID: mdl-28923229
ABSTRACT
Understanding of neuroendocrine tumors has increased greatly in the last 2 decades. Along with this, the prevalence of neuroendocrine tumors has increased because of the ubiquitous use of cross-sectional imaging, improved endoscopic screening, and the indolent nature of the disease. Up to 35% of patients have symptoms at the time of diagnosis, whereas the others have occult disease. Neuroendocrine tumors are a diverse group of malignancies with unique clinical courses. This article critically reviews the most important randomized controlled trials for neuroendocrine tumors and introduces a few awaiting completion.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Ensaios Clínicos Controlados Aleatórios como Assunto
/
Tumores Neuroendócrinos
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article